As part of the NHS’s 10-year plan, Health Secretary Wes Streeting announced that the NHS app will integrate a platform allowing millions of patients to access and enroll in clinical trials, aiming to enhance the UK’s life sciences sector. Despite this advancement, concerns remain about the impact of the UK’s medicine sales tax on pharmaceutical companies’ willingness to conduct trials for innovative drugs in the country.
